# VolitionRx Limited Announces First Quarter 2026 Financial Results and Business Update
***Financial Highlights***
* Revenue for the first quarter was approximately $1.0 million, compared to $0.2 million for the same period in 2025.
* Operating loss was down 3% for the quarter versus the comparable quarter in 2025.
* Net cash used in operating activities was $5.3 million.
* Receipts in the quarter included:
* $5.4 million in net proceeds from equity sales through our at-the-market facility,
* $1.9 million in net proceeds from issuance of a convertible note and warrant, and
* $1 million of non-dilutive funding from agencies of the Walloon Region, with an additional approximate $0.9 million expected to be received in tranches based on certain time and event milestones over the next 12 months.
# [https://finance.yahoo.com/sectors/healthcare/articles/volitionrx-limited-announces-first-quarter-201000328.html](https://finance.yahoo.com/sectors/healthcare/articles/volitionrx-limited-announces-first-quarter-201000328.html)
